However, in breast cancer, the LIFR is known as a metastasis suppressor [48] given its role as an upstream part of the Hippo-YAP pathway: High LIFR expression suppresses metastases by inactivating the transcriptional coactivator YES-associated protein (YAP) through a cascade of multiple phosphorylation processes. Here, LIFR is linked to breast cancer.